The Bode Lab
The Bode Lab

Presentations Archive

May 2017 - Prague, Czech Republic

50th Annual Meeting, ESPGHAN

116.  Bode L  "Human Milk Oligosaccharides at the Interface of Maternal-Infant Health"

April 2017 - Chicago, IL

Experimental Biology, American Society for Nutrition

115.  Bode L  "New Frontiers in Human Milk Oligosaccharide Research"

March 2017 - Perth, Australia

Australian Breastfeeding Association's seminar series

114.  Bode L  "Discovering Functions and Therapeutic Potential of Human Milk Oligosaccharides"

March 2017 - Melbourne, Australia

Australian Breastfeeding Association's seminar series

113.  Bode L  "Discovering Functions and Therapeutic Potential of Human Milk Oligosaccharides"

March 2017 - Sydney, Australia

Australian Breastfeeding Association's seminar series

112.  Bode L  "Discovering Functions and Therapeutic Potential of Human Milk Oligosaccharides"

March 2017 - Brisbane, Australia

Australian Breastfeeding Association's seminar series

111.  Bode L  "Discovering Functions and Therapeutic Potential of Human Milk Oligosaccharides"

February 2017 - San Diego, CA

San Diego Glycobiology Symposium

110.  Bode L  "Biosynthesis and Functions of Human milk oligosaccharides"

October 2016 - Los Angeles, California

9th International Pediatric Intestinal Failure and Rehabilitation Symposium

109.  Bode L  "Enteral Feeding from NICU Perspective: Benefits of Human Milk Oligosaccharides"

October 2016 - La Jolla, California

4th Microbiome R&D and Business Collaboration Forum: USA

Collaborations in Microbiota Research, Probiotics, Health & Disease

108.  Bode L  "Shaping and Controlling the Microbiome with Human Milk Oligosaccharides"

September 2016 - Graz, Austria

1st Mini-Symposium on Human Milk Oligosaccharides in Pregnancy

107.  Bode L  "Short- and long-term Benefits of Human Milk Oligosaccharides"

August 2016 - Tijuana, Mexico

3rd Forum of Lactation, Universidad Autónoma de Baja California

106.  Bode L  "Human Milk Oligosaccharides - Short- and long-term benefits for the breast-fed infant"

August 2016 - Melbourne, Australia

Melbourne Children's Clinical and Public Health Research Seminar

105.  Bode L  "Short- and long-term benefits of Human Milk Oligosaccharides"

August 2016 - Melbourne, Australia

Melbourne School of Population and Global Health Seminar

104.  Bode L  "Impact of Human Milk Oligosaccharides on Short- and Long-term Health"

 

June 2016 - La Jolla, California

University of California, San Diego

Division of Gastroenterology, 10th Annual Research Symposium

103.  Bode L  "Human Milk Oligosaccharides Shape the Infant Microbiome with Potential Health Benefits for Adults"

June 2016 - New Orleans, LA

American Diabetes Association, 76th Scientific Sessions

102.  Bode L  "Bioactive Components of Breast Milk and Evolution of the Infant Microbiome"

June 2016 - La Jolla, California

University of California, San Diego

Center for Immunity, Infection and Inflammation - Guest Lecture

101.  Bode L  "Discovering Functions and Therapeutic Potential of Human Milk Oligosaccharides"

Presentations prior to June 2016

100.  Bode L  (2016) Biology of Milk Oligosaccharides. Invited Speaker, 11th Danish Conference on Biotechnology and Molecular Biology, Vejle, Denmark. (remote presentation)

 
99.  Bode L  (2016) Milk oligosaccharides in Pediatric GI Disease. Invited Speaker, Digestive Disease Week, DDW, San Diego, CA, USA.

 

98.  Bode L  (2016) Novel Clinical Nutrition Strategies for Diegstive Health. Invited Speaker, 24th Annual World Congress on Anti-Aging Medicine, Hollywood, FL, USA.

 

97.  Bode L  (2016) Human milk oligosaccharides contribute to shaping the microbiome early in life. Invited Speaker, 7th Annual Pediatric Faculty Research Symposium, University of California, San Diego, San Diego, CA, USA.

 

96.  Bode L  (2016) Combining preclinical models with mother-infant cohort studies to unravel the benefits of human milk oligosaccharides. Invited Speaker, 11th International Breastfeeding and Lactation Symposium, Berlin, Germany.

 

95.  Bode L  (2016) Specialized Prebiotics to Support Health Outcomes. Invited Speaker, University of Miami, Advances in Clinical Practices for Chronic Conditions, Miami, FL, USA.

 

94. Bode L (2016) Biosynthesis and Functions of Human Milk Oligosaccharides. Invited Speaker. San Diego Glycobiology Symposium, San Diego, CA, USA.

 

93. Bode L (2016) Human milk oligosaccharides as early predictors and potential therapeutics of obesity. Invited Speaker, 18th Conference, International Society for Research in Human Milk and Lactation, Stellenbosch, South Africa.

 

92. Bode L (2016) The power of human cohort studies: Closing the gap between preclinical models and clinical intervention studies. Invited Speaker, 18th Conference, International Society for Research in Human Milk and Lactation, Stellenbosch, South Africa.

 

91. Bode L  (2016) Learning from Mother Nature: Human Milk Oligosaccharides as therapeutics for infants and adults. Invited Speaker, Research Seminar, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA.

 

90.  Bode L  (2015) Back to the future of human milk oligosaccharides. Invited Speaker, University of Zurich, Vision 2020 Lecture, Zurich, Switzerland.

 

89.  Bode L  (2015) The functional biology of human milk oligosaccharides. Invited Speaker. Neonatal Update 2015, "the science of newborn care", London, UK.

 

88. Bode L  (2015) Dietary Effects on the Microbiome: Learning from Mother Nature. Invited Speaker. Nutrition Pro 2015: Medical Nutrition Therapy in Practice, Orlando, FL, USA.

 

87. Bode L  (2015) Oligosaccharides in Human Milk and their contributions to neonatal health and disease. Invited Speaker. California Association of Neonatologists (CAN), California NICU Medical Directors Meeting, Los Gatos, CA, USA.

 

86.  Bode L  (2015) Effects of the Microbiome on Immunity. What determines the microbiome early in life? An Introduction to Human Milk Oligosaccharides. Invited Speaker. AABB Annual Meeting, Anaheim, CA, USA.

 

85.  Bode L  (2015) A Research Update on Human milk oligosaccharides. Invited Speaker. Research Seminar, UCSD Pediatric Gastroenterology, Hepatology and Nutrition, San Diego, CA, USA.

 

84.  Bode L  (2015) Human milk oligosaccharides: Lessons learned from basic science research for outcomes affecting the infant in the developing. Invited Speaker. 1st Human Milk and Lactation Symposium: From Bench to Lebanese Baby, Notre Dame University-Zouk Mosbeh, Beirut, Lebanon.

 

83.  Bode L  (2015) An Introduction to Human Milk Oligosaccharides. Invited Speaker. FASEB SRC - Origins and Benefits of Biologically Active Components in Human Milk. Big Sky, MT, USA.

 

82.  Bode L  (2015) Human Milk Oligosaccharides in the Prevention of Necrotizing Enterocolitis. Invited Speaker. Pediatric Grand Rounds. Betty H. Cameron Women's and Children's Hospital, New Hanover Regional Medical Center, NC, USA.

 

81.  Bode L  (2015) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker. Coastal Carolina Neonatology, Dinner Keynote Lecture. Wilmington, NC, USA.

 

80. Bode L (2015) Human Milk Oligosaccharides as primers of the infant microbiome. Invited Speaker. Old Herborn University Seminar, Herborn, Germany.

 

79. Bode L (2015) Human Milk Oligosaccharides and their Benefits for Infants. Invited Speaker. BINC - Biostime Institute of Nutrition and Care, Hangzhou, China.

 

78. Bode L (2015) Human Milk Oligosaccharides: Natural Prebiotics and Beyond. Invited Speaker. Metagenics Educational Seminar Series, Austin, TX, USA.

 

77. Bode L (2015) Human Milk Oligosaccharides: The Power of Cohort Studies. Invited Speaker. Grand Rounds, UCSD Department of Medicine, Division of Gastroenterology, San Diego, CA, USA.

 

76. Bode L (2015) Perinatal Nutrition and Metabolism Club: Human Milk Oligosaccharides: Influences on Neonatal Health and Disease. Pediatric Academic Societies (PAS) Meeting, San Diego, CA, USA.

 

75. Bode L (2015) Interactions between breastmilk oligosaccharides and mother/infant microbiome. Invited Speaker. International Human Microbiome Consortium (IHMC) Congress, Luxemburg.

 

74. Bode L (2015) Human Milk Oligosaccharides as direct and indirect primers of the infant microbiome. Invited Speaker. Gordon Research Conference - Glycobiology, Lucca (Barga), Italy.

 

73. Bode L (2015) Biosynthesis and Functions of Human Milk Oligosaccharides. Invited Speaker. San Diego Glycobiology Symposium, San Diego, CA, USA.

 

72. Bode L (2014) Introduction to Microbiome Glycomics. Workshop Co-chair and Speaker. Society for Glycobiology, Annual Meeting, Honolulu, Hawaii, USA.

 

71. Bode L (2014) Human Milk Oligosaccharides as Primers for the Infant Gut. Invited Speaker. 17th Conference of the International Society for Research in Human Milk and Lactation, Kiawah Island, SC, USA.

 

70. Bode L (2014) Benefits of Human Milk Oligosaccharides for the Breastfed Infant. Invited Speaker. 2nd Annual International Conference on Human Milk Science & Innovation. Santa Monica, CA, USA.

 

69.  Bode L  (2014) Functionality of Human Milk Oligosaccharides. Invited Speaker, Research Seminar. Wageningen University, The Netherlands.

 

68.  Bode L (2014) Functionality of Milk Oligosaccharides: Only the Tip of the Sugarloaf? Invited Speaker. 7th International Whey Conference, Rotterdam, The Netherlands.

 

67.  Bode L (2014) Human milk oligosaccharides as natural drug templates. Invited Speaker, Research Seminar. Technical University Munich, Munich, Germany.

 

66.  Bode L (2014) Milch Oligosaccharide und die Symbiose von Mutter, Kind und Bakterien. [German] Invited Speaker. 40th Annual Meeting of the Society for neonatology and pediatric intensive care medicine, Bonn, Germany.

 

65.  Bode L (2014) Milk Oligosaccharides. Invited Speaker. National Institutes of Health, “Exploring the Frontiers of Chemical Glycoscience”, Bethesda, MD, USA.

 

64.  Bode L (2014) Human Milk Oligosaccharides: The Role of Breast Milk Prebiotics in Selecting the Infant Microbiome. Invited Speaker. DDW - Digestive Disease Week, Chicago, IL, USA.

 

63.  Bode L (2014) Sialylated Oligosaccharides in Human Milk and their Role in Infant Physiology and Disease Prevention. Invited Speaker, EB - Experimental Biology, San Diego, CA, USA.

 

62.  Bode L (2014) An Introduction to Human Milk Oligosaccharides and their Potential Benefits for the Breastfed Infant and the Breastfeeding Mother. Invited Speaker, EB - Experimental Biology, San Diego, CA, USA.

 

61.  Bode L (2014) Oligosaccharides in Human Milk. Invited Speaker, Research Seminar, Stellenbosch University, Stellenbosch/Cape Town, South Africa.

 

60.  Bode L (2014) Human Milk Oligosaccharides: An Update from the Milk Gang. Invited Speaker. San Diego Glycobiology Symposium, San Diego, CA, USA.

 

59.  Bode L (2014) Oligosaccharides and Nutrition. Invited Speaker. NEO - The Conference for Neonatology, Orlando, FL, USA.

 

58.  Bode L (2014) Human Milk Oligosaccharides: Every Baby needs a Sugar Mama. Invited Speaker, Research Seminar, Complex Carbohydrate Research Center (CCRC), University of Georgia, Athens, GA, USA. 

 

57.   Bode L (2014) Natural protection: Human milk oligosaccharides in the prevention of infectious diseases. Invited Speaker. Pediatric Infectious Disease Conference, University of California, San Diego, CA, USA.

 

56.  Bode L (2013) Human Milk Oligosaccharides: An Update from the Milk Gang. Invited Speaker, Hillcrest Biomedical and Clinical Research Seminar, University of California, San Diego, San Diego, CA, USA.

 

55.  Bode L (2013) Forschung aktuell: Oligosaccharide in der Muttermilch [German]. Invited Speaker, 8th Deutschen Still- und Laktationskongress - 8th German Breastfeeding and Lactation Conference, Freie Universitaet Berlin, Berlin, Germany.

 

54.  Bode L (2013) Human Milk Oligosaccharides: Why Glycans Matter”. Invited Speaker, Children’s Hospital Los Angeles, The Saban Research Institute, Research Seminar, Los Angeles, CA, USA.

 

53.  Bode L (2013) Use of Human Milk Oligosaccharides and Infant Formula. Invited Speaker, International Scientific Association For Probiotics and Prebiotics and
The Sackler Institute for Nutrition Science at the New York Academy of Science
, New York, NY, USA.

 

52.  Bode L (2013) Human Milk Oligosaccharides in the Prevention of Necrotizing Enterocolitis. Invited Speaker, American Academy of Pediatrics Perinatal Section, 82nd Perinatal & Developmental Medicine Symposium, Aspen, CO, USA.

 

51.  Bode L (2013) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, American Academy of Pediatrics Perinatal Section, 82nd Perinatal & Developmental Medicine Symposium, Aspen, CO, USA.

 

50.  Bode L (2013) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, 9th Annual Carbohydrate Symposium, Alberta Glycomics Centre, Banff, Canada.

 

49.  Bode L (2013) Human Milk Oligosaccharides: A Spoonful of Oligo-Sugar. Invited Speaker, Annual Dialogues in Neonatal-Perinatal Medicine Conference, Duke University Medical Center, Durham, NC, USA.

 

48.  Bode L (2013) Human Milk Oligosaccharides: Antimicrobials in the context of amebiasis, mother-to-child HIV transmission, and necrotizing enterocolitis. Invited Speaker, National Institutes of Health, Workshop on Bioactive Glycans in Human Milk, Bethesda, MD, USA.

 

47.  Bode L (2013) Human Milk Oligosaccharides: Two Short Stories and a Hairy Monster. Invited Speaker, Department of Pediatrics Faculty Research Symposium, UCSD / Rady Children’s Hospital, San Diego, CA, USA.

 

46.  Bode L (2013) Human Milk Oligosaccharides: An Update from the “Milk Gang. Invited Speaker, 16th Annual Glycobiology Symposium, Glycobiology Research and Training Center, San Diego, CA, USA.

 

45.  Bode L (2012) Human Milk Oligosaccharides: Why Glycans Matter. Invited Speaker, Research Seminar, Digestive Disease Center, Baylor College of Medicine, Houston, TX, USA.

 

44.  Bode L (2012) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, Research Seminar, Washington State University, School of Biological Sciences, Pullman, WA, USA.

 

43.  Bode L (2012) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, Research Seminar, Technical University Munich, Molecular Nutrition Department, Munich, Germany.

 

42.  Bode L (2012) The Role of Oligosaccharides in the Protection from NEC: Data from an Original Study. Invited Speaker, 16th Conference of the International Society for Research in Human Milk and Lactation, Trieste, Italy.

 

41.  Bode L (2012) Human Milk Oligosaccharides: Structure-Function Relationships in the Context of Infant Disease. Invited Speaker, 16th Conference of the International Society for Research in Human Milk and Lactation, Trieste, Italy.

 

40.  Bode L (2012) Human Milk Oligosaccharides and the Benefits for the Breastfed Infant. Invited Speaker, Seminar, World Breastfeeding Week, San Diego County Breastfeeding Coalition, San Diego, CA, USA.

 

39.  Bode L (2012) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, Grand Rounds, Rady Children’s Hospital San Diego, San Diego, CA, USA.

 

38.  Bode L (2012) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, 7th International Breastfeeding and Lactation Symposium, Vienna, Austria.

 

37.  Bode L (2012) Human Milk Oligosaccharides: A Research Update. Invited Speaker. 5th Annual Glycobiology Symposium, Glycobiology Research and Training Center, San Diego, CA, USA

 

36.  Bode L (2011) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, Pediatrics Faculty Research Seminar, UCSD Department of Pediatrics, San Diego, CA, USA.

 

35.  Bode L (2011) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, Research Seminar, UCSD Department of Medicine, San Diego, CA, USA.

 

34.  Bode L (2011) Pre-, Pro-, Synbiotics and beyond. Invited Speaker, Neonatal and Pediatric Nutrition Conference: Update 2011, San Diego, CA. USA.

 

33.  Bode L (2011) All I need to know about Nutritional Science: for the Healthcare Professional. Invited Speaker, Neonatal and Pediatric Nutrition Conference: Update 2011, San Diego, CA. USA.

 

32.  Bode L (2011) Human Milk Oligosaccharides prevent Necrotizing Enterocolitis in Neonatal Rats. Invited Speaker, 44th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), Sorrento, Italy.

 

31.  Bode L (2011) Human Milk Oligosaccharides in Amebiasis and Necrotizing Enterocolitis. Invited Speaker, 1st International Conference on the Glycobiology of Human Milk Oligosaccharides, Copenhagen, Denmark.

 

30.  Bode L (2011) Human Milk Oligosaccharides. Invited Speaker, 5th Glycan Forum, Berlin, Germany.

 

29.  Bode L (2011) Human Milk Oligosaccharides: A Research Update.  Invited Speaker, 14th Annual Glycobiology Symposium, Glycobiology Research and Training Center, San Diego, CA, USA.

 

28.  Bode L (2010) Human Milk Oligosaccharides: Prebiotics and More. Invited Speaker, Neonatal and Pediatric Nutrition: Update 2010. San Diego, CA, USA.

 

27.  Bode L (2010) Nutrition Science Primer for the Healthcare Practitioner. Invited Speaker, Neonatal and Pediatric Nutrition: Update 2010. San Diego, CA, USA.

 

26.  Bode L (2010) Human Milk Oligosaccharides Prevent Necrotizing Enterocolitis in a Rat Model. Selected Speaker. Experimental Biology. Anaheim, CA, USA.

 

25.  Bode L (2010) Human Milk Oligosaccharides in the Prevention of Necrotizing Enterocolitis. Invited Speaker. Pediatric Grand Rounds. University of California, San Diego, CA, USA.

 

24.  Bode L (2010) Human Milk Oligosaccharides: A Research Perspective. Invited Speaker. Columbus, OH, USA.

 

23.  Bode L (2009) Human Milk Oligosaccharides prevent Necrotizing Enterocolitis in an animal model. Invited Speaker. Scripps Mercy Hospital, San Diego, CA, USA.

 

22.  Bode L (2009) Human Milk Oligosaccharides in the prevention of Childhood Diseases. Invited Speaker. Sanford Children’s Health Research Symposium. Sioux Falls, SD, USA.

 

21.  Bode L (2009) Human Milk Oligosaccharides. Invited Speaker. Sharp Mary Birch Hospital for Women, San Diego, CA, USA.

 

20.  Bode L (2009) Human milk oligosaccharides – Only the breast. Guest Speaker. Joint Fellows’ Neonatal Conference. TriCity Medical Center, CA, USA.

 

19.  Bode L (2009) Functions and Biosynthesis of Human Milk Oligosaccharides. Invited Speaker, San Diego Glycobiology Symposium, San Diego, CA, USA.

 

18.  Bode L (2008) Human milk oligosaccharides – Prebiotics and Beyond. Invited Speaker, Mexico City, Mexico.

 

17.  Bode L (2008) Human milk oligosaccharides – Biosynthesis, Functions, Clinical Implications. Invited Speaker, Research Seminar, Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern California, CA, USA.

 

16.  Bode L (2008) Human milk oligosaccharides: Can Mom’s sugars prevent Necrotizing Enterocolitis? Invited Speaker, Research Seminar, Gastroenterology Department, University of California San Diego, San Diego, CA, USA.

 

15.  Bode L (2008) Human milk oligosaccharides – Biosynthesis, Function, Clinical Implication. Invited Speaker, Research Seminar, Pediatrics Department, Neonatology Division, University of California San Diego, San Diego, CA, USA.

 

14.  Bode L (2007) Human milk oligosaccharides – Only the breast. Invited speaker, Research Seminar, University of California Davis, CA, USA.

 

13.  Bode L (2007) Human milk oligosaccharides – A Multidisciplinary Approach. Invited speaker, Philadelphia.

 

12.  Bode L (2006) Central role of heparan sulphate proteoglycans in preventing intestinal epithelial protein leakage. Lessons for the endothelial barrier? Invited speaker, 24th European Conference on Microcirculation. Amsterdam, the Netherlands.

 

11.  Bode L (2006) Protein losing enteropathy: from clinical observations to basic research; from basic research to clinical applications. Invited speaker, Gastrointestinal Research Seminar, University of California San Diego. San Diego, CA, USA.

 

10.  Bode L (2006) Inhibiting the signal before it strikes – Central role of heparan sulphate and heparan in pathogenesis and therapy of protein-losing enteropathy. Invited guest speaker, Signal Transduction Program Retreat. San Diego, CA, USA.

 

9.  Bode L, Park PW, Murch S, Freeze HH (2006) Loss of cell-associated heparan sulfate (HS) amplifies IFNγ- and TNFα-induced protein leakage in a model of Protein-Losing Enteropathy (PLE). Experimental Biology Meeting, San Francisco, CA, USA. 

 

8.  Bode L, Park PW, Murch S, Freeze HH (2005) Loss of cell-associated heparan sulfate amplifies IFNγ- and TNFα-induced protein leakage in a model of Protein-Losing Enteropathy. 16th Joint Meeting of Glycobiology, Hannover, Germany.

 

7.  Bode L, Salvestrini C, Murch S, Park PW, Linhardt RJ, Freeze HH (2005) Proposed molecular mechanisms of protein-losing enteropathy. Gordon Research Conference Glycobiology, Ventura, CA, USA.

 

6.  Bode L, Eklund EA, Salvestrini C, Murch S, Freeze HH (2004) An in vitro cellular model of protein- losing enteropathy implicates heparan sulfate, inflammatory cytokines, and hydrostatic pressure as critical players. ESPGHAN world meeting, Paris, France. Journal of Pediatric Gastroenterology and Nutrition 39: S59

 

5.  Bode L, Rudloff S, Kunz C, Strobel S, Klein N (2004) Human milk oligosaccharides reduce platelet- neutrophil complex formation and suppress neutrophil beta 2 integrin expression. Experimental Biology Meeting, Washington, DC, USA. The FASEB Journal 18: A843-4

 

4.  Bode L (2003) Human milk oligosaccharides as inhibitors of selectin-mediated cell-cell interactions. Invited speaker, scientific seminar, The Technical University of Denmark, BioCentrum-DTU, Section for Biochemistry and Nutrition, Lyngby, Denmark.

 

3.  Bode L, Rudloff S (2002) Einfluss von Humanmilch-Oligosacchariden auf die Adhäsion von Monozyten an Endothelzellen. [German] 39th Meeting of the German Nutrition Society, Jena, Germany. Proceedings of the German Nutrition Society 4: 17

 

2.  Bode L (2002) Effects of human milk oligosaccharides on leukocyte adhesion to endothelial cells. The Summer Course Glycoscience, Wageningen, the Netherlands

 

1.  Bode L, Rudloff S (2001) Mögliche systemische Effekte von Humanmilch Oligosacchariden (HMO)– Ein in vitro Modell. [German] 97th Meeting of the German Paediatric Society, Freiburg, Germany. Monatsschrift Kinderheilkunde 149: S132

Dedicated to Research on Human Milk Oligosaccharides

Print Print | Sitemap
© lars bode